Matches in SemOpenAlex for { <https://semopenalex.org/work/W2468752685> ?p ?o ?g. }
- W2468752685 endingPage "345" @default.
- W2468752685 startingPage "332" @default.
- W2468752685 abstract "1. To understand the clearance mechanism of luseogliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, we investigated its human metabolite profile and metabolic enzymes responsible for the primary metabolic pathways in human using reaction phenotyping. 2. Sixteen metabolites of luseogliflozin were found in human plasma and/or urine and their structural information indicated that the drug was metabolized via multiple metabolic pathways. The primary metabolic pathways involve (1) O-deethylation to form M2 and subsequent glucuronidation to form M12, (2) ω-hydroxylation at ethoxy group to form M3 followed by oxidation to form the corresponding carboxylic acid metabolite (M17) and (3) direct glucuronidation to form M8. 3. The reaction phenotyping studies indicated that the formation of M2 was mainly mediated by cytochrome P450 (CYP) 3A4/5, and subsequently M12 formation was catalyzed by UGT1A1, UGT1A8 and UGT1A9. The formation of M3 was mediated by CYP4A11, CYP4F2 and CYP4F3B, and the further oxidation of M3 to M17 was mediated by alcohol dehydrogenase and aldehyde dehydrogenase. The formation of M8 was catalyzed by UGT1A1. 4. These results demonstrate that luseogliflozin is metabolized through multiple pathways, including CYP-mediated oxidation and glucuronidation, in human." @default.
- W2468752685 created "2016-07-22" @default.
- W2468752685 creator A5023393085 @default.
- W2468752685 creator A5024748040 @default.
- W2468752685 creator A5027382489 @default.
- W2468752685 creator A5034526773 @default.
- W2468752685 creator A5051131785 @default.
- W2468752685 creator A5053229206 @default.
- W2468752685 creator A5058263346 @default.
- W2468752685 creator A5061016066 @default.
- W2468752685 creator A5068587130 @default.
- W2468752685 creator A5079265287 @default.
- W2468752685 creator A5089842565 @default.
- W2468752685 creator A5088283713 @default.
- W2468752685 date "2016-06-27" @default.
- W2468752685 modified "2023-10-18" @default.
- W2468752685 title "Metabolite profiling and enzyme reaction phenotyping of luseogliflozin, a sodium–glucose cotransporter 2 inhibitor, in humans" @default.
- W2468752685 cites W1561949950 @default.
- W2468752685 cites W1647405314 @default.
- W2468752685 cites W1778584949 @default.
- W2468752685 cites W1784102749 @default.
- W2468752685 cites W1966820517 @default.
- W2468752685 cites W1979431461 @default.
- W2468752685 cites W1981489325 @default.
- W2468752685 cites W1982589515 @default.
- W2468752685 cites W1985015752 @default.
- W2468752685 cites W1988743489 @default.
- W2468752685 cites W1994405711 @default.
- W2468752685 cites W2006282304 @default.
- W2468752685 cites W2008844950 @default.
- W2468752685 cites W2011321815 @default.
- W2468752685 cites W2019009103 @default.
- W2468752685 cites W2024840449 @default.
- W2468752685 cites W2027548206 @default.
- W2468752685 cites W2034632234 @default.
- W2468752685 cites W2038961968 @default.
- W2468752685 cites W2039955326 @default.
- W2468752685 cites W2040611122 @default.
- W2468752685 cites W2042291132 @default.
- W2468752685 cites W2045013775 @default.
- W2468752685 cites W2052976889 @default.
- W2468752685 cites W2052997601 @default.
- W2468752685 cites W2063003329 @default.
- W2468752685 cites W2065399738 @default.
- W2468752685 cites W2065474611 @default.
- W2468752685 cites W2075156087 @default.
- W2468752685 cites W2076851249 @default.
- W2468752685 cites W2081213990 @default.
- W2468752685 cites W2086031167 @default.
- W2468752685 cites W2088013207 @default.
- W2468752685 cites W2090563376 @default.
- W2468752685 cites W2091582819 @default.
- W2468752685 cites W2103196856 @default.
- W2468752685 cites W2107051243 @default.
- W2468752685 cites W2107255243 @default.
- W2468752685 cites W2108136678 @default.
- W2468752685 cites W2110482855 @default.
- W2468752685 cites W2111668019 @default.
- W2468752685 cites W2116545934 @default.
- W2468752685 cites W2127861507 @default.
- W2468752685 cites W2140406340 @default.
- W2468752685 cites W2152211669 @default.
- W2468752685 cites W2152222584 @default.
- W2468752685 cites W2152991448 @default.
- W2468752685 cites W2159079439 @default.
- W2468752685 cites W2165886950 @default.
- W2468752685 cites W2340005443 @default.
- W2468752685 cites W4211124708 @default.
- W2468752685 doi "https://doi.org/10.1080/00498254.2016.1193263" @default.
- W2468752685 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27347703" @default.
- W2468752685 hasPublicationYear "2016" @default.
- W2468752685 type Work @default.
- W2468752685 sameAs 2468752685 @default.
- W2468752685 citedByCount "14" @default.
- W2468752685 countsByYear W24687526852016 @default.
- W2468752685 countsByYear W24687526852017 @default.
- W2468752685 countsByYear W24687526852018 @default.
- W2468752685 countsByYear W24687526852019 @default.
- W2468752685 countsByYear W24687526852020 @default.
- W2468752685 countsByYear W24687526852021 @default.
- W2468752685 countsByYear W24687526852022 @default.
- W2468752685 countsByYear W24687526852023 @default.
- W2468752685 crossrefType "journal-article" @default.
- W2468752685 hasAuthorship W2468752685A5023393085 @default.
- W2468752685 hasAuthorship W2468752685A5024748040 @default.
- W2468752685 hasAuthorship W2468752685A5027382489 @default.
- W2468752685 hasAuthorship W2468752685A5034526773 @default.
- W2468752685 hasAuthorship W2468752685A5051131785 @default.
- W2468752685 hasAuthorship W2468752685A5053229206 @default.
- W2468752685 hasAuthorship W2468752685A5058263346 @default.
- W2468752685 hasAuthorship W2468752685A5061016066 @default.
- W2468752685 hasAuthorship W2468752685A5068587130 @default.
- W2468752685 hasAuthorship W2468752685A5079265287 @default.
- W2468752685 hasAuthorship W2468752685A5088283713 @default.
- W2468752685 hasAuthorship W2468752685A5089842565 @default.
- W2468752685 hasConcept C181199279 @default.
- W2468752685 hasConcept C185592680 @default.
- W2468752685 hasConcept C192989942 @default.